CLA Dosage: How Much to Take (and Why More Isn't Better)

By Erin Rose · Updated July 20, 2026 · Methodology

Educational summary — not medical advice. See the hub for the metabolic-risk safety context before dosing, especially if you have diabetes, prediabetes, or metabolic syndrome. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

The dose that most of the human evidence uses

When researchers pooled 18 randomized, placebo-controlled human trials, the dose-response relationship they found centered on 3.2 g/day — a dose that produced about 0.09 kg/week of fat loss versus placebo (Whigham 2007). That figure is the practical anchor for "how much CLA," not because it's an official RDA (there isn't one) but because it's the dose with the most pooled human evidence behind it. Individual trials used a range of doses: Blankson 2000 tested five arms from 1.7 to 6.8 g/day and found no additional fat-mass benefit above 3.4 g/day; Gaullier 2004 used 3.4 g/day for a full year; Steck 2007 compared 3.2 versus 6.4 g/day and found the higher dose came with a drop in HDL cholesterol and a rise in CRP and IL-6.

The isomer blend, explained

Most retail CLA — including Tonalin-brand, safflower-derived products — is a roughly 50:50 blend of two isomers: cis-9,trans-11 (c9,t11) and trans-10,cis-12 (t10,c12). The purified t10,c12 isomer alone is the one specifically linked to the insulin-resistance and oxidative-stress signal in controlled trials (see the full evidence), and it's generally a research-only preparation, not something sold standalone at retail. It would be convenient to conclude "just buy the blend, the risk is only in the isolated isomer" — but the evidence doesn't fully support that: Moloney 2004 gave type 2 diabetics a standard 50:50 blend at 3.0 g/day for 8 weeks and still found a significant rise in fasting glucose and a drop in insulin sensitivity. So the isomer distinction matters for understanding the mechanism, but it doesn't fully clear the retail-typical blend of the metabolic-risk question.

How to take it

• Target ~3.2 g/day — the dose with the most pooled human evidence behind it, and check your label's math before assuming "1 serving" gets you there.
• Don't chase a higher dose expecting more fat loss. Blankson 2000 found no added benefit above 3.4 g/day, and Steck 2007 found the higher 6.4 g/day dose came with lower HDL and higher inflammation markers, not extra fat loss worth the trade-off.
• Split into 2–3 doses with meals — the pattern most trials used, and it may reduce GI upset (a common complaint across trials).
• Check whether the label states CLA directly or a total softgel/oil weight that includes non-CLA fatty acids — see the label-transparency callout for a real example.
• Have diabetes, prediabetes, or metabolic syndrome? Read the safety note on the hub and talk to a clinician first — this is the population the adverse glucose/insulin signal was measured in.

Frequently asked questions

Related

• CLA: what it is & who it's for
• Best CLA — ranked by cost per gram, plus the label-transparency callout
• CLA for fat loss — realistic expectations before you buy
• Does CLA actually work? — the animal-vs-human gap, explained

Sources